SCHEMBL2570993

SCHEMBL2570993

CN1CCc2ccc(NC(=O)[C@@](C)(COCCCC(=O)O)NC(=O)Oc3ccc(Cl)s3)cc2CC1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.33
RAB9A P51151 1/20 0.33
HDAC1 Q13547 1/20 0.33
HDAC2 Q92769 1/20 0.33
PSEN1 P49768 1/20 0.32
PSEN2 P49810 1/20 0.32
APH1B Q8WW43 1/20 0.32
NCSTN Q92542 1/20 0.32
APH1A Q96BI3 1/20 0.32
PSENEN Q9NZ42 1/20 0.32
F10 P00742 2/20 0.32
KDM4E B2RXH2 1/20 0.32
AR P10275 5/20 0.32
MCHR1 Q99705 1/20 0.32
DRD2 P14416 1/20 0.31
HTR2C P28335 1/20 0.31
DRD3 P35462 1/20 0.31
HTR6 P50406 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31
ROCK2 O75116 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2568026 0.93 PSEN1 (0.33) NPC1RAB9AHDAC1HDAC2PSEN1
SCHEMBL3032956 0.88 F10 (0.43) NPC1RAB9AF10KDM4EAR
SCHEMBL2571305 0.87 KDM4E (0.36) NPC1RAB9AHDAC1HDAC2PSEN1
SCHEMBL2566978 0.87 HRH3 (0.37) NPC1RAB9APSEN1PSEN2APH1B
SCHEMBL2568969 0.85 RAB9A (0.36) NPC1RAB9AHDAC1HDAC2PSEN1
SCHEMBL2571214 0.84 KDM4E (0.40) NPC1RAB9AHDAC1HDAC2PSEN1
SCHEMBL2568110 0.83 HDAC1 (0.34) NPC1RAB9AHDAC1HDAC2PSEN1
SCHEMBL2571863 0.82 RAB9A (0.34) NPC1RAB9AHDAC1HDAC2PSEN1
SCHEMBL2567154 0.82 AR (0.33) NPC1RAB9AHDAC1HDAC2PSEN1
SCHEMBL3017690 0.81 F10 (0.42) NPC1RAB9APSEN1PSEN2APH1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1899330-B9 SUBSTITUTED GLYCINAMIDES HAVING AN ANTITHROMBOTIC AND FACTOR XA-INHIBITING EFFECT BOEHRINGER INGELHEIM INT (DE) 2011-11-09 EP disclosed
EP-1899330-B1 SUBSTITUTED GLYCINAMIDES HAVING AN ANTITHROMBOTIC AND FACTOR XA-INHIBITING EFFECT BOEHRINGER INGELHEIM INT (DE) 2010-11-24 EP disclosed